CHESTER, N.J., April 24 /PRNewswire-FirstCall/ -- Adams Respiratory Therapeutics, Inc. is scheduled to announce its sales and earnings results for the fiscal third quarter of 2007 on Thursday, May 10, 2007, before the market opens. At 9:00 a.m. (EDT) on that day, Adams management will conduct a conference call to review the fiscal third quarter results.
To listen live to the call, dial 1-877-669-8882 or 1-706-758-9391. A replay of the call will be available starting at approximately 12 p.m. on May 10 through 5 p.m. on May 17. To listen to the replay, dial 1-800-642-1687 or 1-706-645-9291 and enter the conference ID# 6531289.
A live audio webcast of the conference call also will be available by going to the Investor Relations section of the Adams web site, http://www.adamsrt.com. A replay of the webcast will be available starting at approximately 11 a.m. on May 10 through 5 p.m. on June 7.
About Adams Respiratory Therapeutics, Inc.
Adams is a specialty pharmaceutical company focused on the late-stage development, commercialization and marketing of over-the-counter and prescription pharmaceuticals for the treatment of respiratory disorders.
Adams Respiratory Therapeutics, Inc.
CONTACT: Investor-Media Contact, Janet M. Barth of Adams RespiratoryTherapeutics, Inc., +1-908-879-2428
Web site: http://www.adamsrt.com//
